To the Point
Drug-maker Mylan and its $300 "generic" EpiPen
Mylan might or might not have good news for people who need EpiPens. They provide quick injections to protect against potentially deadly anaphylactic shock from bee stings, peanut allergies and other sources. The drug company is still increasing the price of two EpiPens to $600 — while it also produces a so-called "generic" for $300.
By Warren Olney • • 1 min readMylan might or might not have good news for people who need EpiPens. They provide quick injections to protect against potentially deadly anaphylactic shock from bee stings, peanut allergies and other sources. The drug company is still increasing the price of two EpiPens to $600 — while it also produces a so-called "generic" for $300. Andrew Pollack covers the business and science of biotechnology for the New York Times.
The full episode
1 of 3
Did Trump betray his base on immigration?- 1:51Drug-maker Mylan and its $300 "generic" EpiPenYou’re reading this
- 8:47When is a policy not a policy?
- 41:48The sanction of contract killings in the Philippines
The full episode
1 of 3Did Trump betray his base on immigration?- 1:51Drug-maker Mylan and its $300 "generic" EpiPenYou’re reading this
- 8:47When is a policy not a policy?
- 41:48The sanction of contract killings in the Philippines